A clinically validated, non-invasive Low Level Laser Therapy technique that uses high-intensity, multiple-wavelength LED panels to deliver precise, non-thermal light energy. This energy is absorbed by mitochondrial chromophores — primarily cytochrome c oxidase — to stimulate cellular metabolism, increase ATP (adenosine triphosphate) production, and promote a cascade of biological responses including accelerated tissue repair, reduced inflammation, and pain relief.
Beyond Red Light: What Multi-Wavelength Photobiomodulation Adds
Red light can be part of photobiomodulation — but wavelength is only one part of the equation. Photobiomodulation also considers dose, irradiance, pulse structure, exposure time and the treatment target. The ATP38 uses six wavelength bands characterized in peer-reviewed research within a programmable, multi-panel PBM system — so the protocol, not just the color, defines the treatment.
ATP38 Photobiomodulation 4th generation of Swiss Excellence
ATP38 is the 4th next-generation photobiomodulation system that sets new standard in non-invasive light therapy by delivering uniform, 6-wavelength LED energy over large surface areas with medical-grade precision — enhancing cellular recovery, reducing inflammation, and accelerating healing without heat or downtime. Unlike traditional PBM devices, ATP38 combines multi-panel, high-output design with targeted wavelength modulation to ensure consistent energy delivery, making it more effective, faster-acting, and suitable for a broader range of clinical and wellness applications.